Sangamo Nearing Fabry Gene Therapy Deal To Fund Its Pipeline

New Hemophilia Partners Also Circling

 
• By Mandy Jackson
  
Sangamo will sign a deal for its Fabry disease gene therapy imminently (Shutterstock)

More from Deals

More from Leadership